Published in J Biomed Mater Res on March 01, 1989
Significance of bacterial surface-active compounds in interaction of bacteria with interfaces. Microbiol Rev (1996) 2.56
Protein adsorption on surfaces with grafted polymers: a theoretical approach. Biophys J (1997) 2.26
Measurements of attractive forces between proteins and end-grafted poly(ethylene glycol) chains. Proc Natl Acad Sci U S A (1997) 1.89
Structure and phase behavior of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol). Biophys J (1995) 1.75
Nanoporous membranes for medical and biological applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.22
A functionalized poly(ethylene glycol)-based bioassay surface chemistry that facilitates bio-immobilization and inhibits non-specific protein, bacterial, and mammalian cell adhesion. Chem Mater (2007) 1.12
Imaging surface immobilization chemistry: correlation with cell patterning on non-adhesive hydrogel thin films. Adv Funct Mater (2008) 0.96
Nonfouling NTA-PEG-Based TEM Grid Coatings for Selective Capture of Histidine-Tagged Protein Targets from Cell Lysates. Langmuir (2016) 0.83
MMA/MPEOMA copolymers as coating materials for improved blood compatibility: protein adsorption study. J Mater Sci Mater Med (2004) 0.82
Fluorocarbon Surfactant Polymers: Effect of Perfluorocarbon Branch Density on Surface Active Properties. Macromolecules (2004) 0.81
Long-Term Controlled Protein Release from Poly(Ethylene Glycol) Hydrogels by Modulating Mesh Size and Degradation. Macromol Biosci (2015) 0.79
Polymeric membrane materials for artificial organs. J Artif Organs (2008) 0.77
The efficacy of an acrylic intraocular lens surface modified with polyethylene glycol in posterior capsular opacification. J Korean Med Sci (2007) 0.76
Design of surface modifications for nanoscale sensor applications. Sensors (Basel) (2015) 0.75
Ultrasmall Conjugated Polymer Nanoparticles with High Specificity for Targeted Cancer Cell Imaging. Adv Sci (Weinh) (2017) 0.75
Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains. Nature (1999) 1.78
Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. J Biomed Mater Res (1987) 1.60
First clinical application of transarterial closed-chest left ventricular (TaCLV) bypass. Trans Am Soc Artif Intern Organs (1970) 1.46
Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J Control Release (1998) 1.45
Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. Int J Cancer (2000) 1.34
HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J Control Release (1998) 1.33
Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice. Eur J Cancer (2001) 1.30
Soluble biomedical polymers. Polim Med (1977) 1.28
The foreign body reaction: a chronic inflammatory response. J Biomed Mater Res (1974) 1.17
Interfacial phenomena and biomaterials. Med Instrum (1973) 1.16
Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line. J Control Release (1999) 1.12
Surface properties of copolymers of alkyl methacrylates with methoxy (polyethylene oxide) methacrylates and their application as protein-resistant coatings. Biomaterials (1990) 1.07
Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats. Biochim Biophys Acta (1986) 1.04
Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl)methacrylamide copolymers. Biochim Biophys Acta (1984) 1.03
Novel pH-sensitive hydrogels with adjustable swelling kinetics. Biomaterials (1998) 1.00
Hybrid hydrogels cross-linked by genetically engineered coiled-coil block proteins. Biomacromolecules (2001) 1.00
Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells. Pharm Res (1999) 0.99
Long-term experience with poly(glycol monomethacrylate) gel in plastic operations of the nose. J Biomed Mater Res (1975) 0.98
The pharmacokinetics of polymer-bound adriamycin. Biochem Pharmacol (1990) 0.98
Surface modification and evaluation of some commonly used catheter materials. I. Surface properties. J Biomed Mater Res (1983) 0.97
Polymerizable Fab' antibody fragments for targeting of anticancer drugs. Nat Biotechnol (1999) 0.97
Controlled biodegradability of polymers--a key to drug delivery systems. Biomaterials (1984) 0.97
Enhanced biorecognition and internalization of HPMA copolymers containing multiple or multivalent carbohydrate side-chains by human hepatocarcinoma cells. Bioconjug Chem (2001) 0.95
Feasibility of using a bone-targeted, macromolecular delivery system coupled with prostaglandin E(1) to promote bone formation in aged, estrogen-deficient rats. Pharm Res (2008) 0.95
Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. Eur J Cancer (2004) 0.94
HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro. J Drug Target (1996) 0.94
Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments. Clin Cancer Res (2000) 0.93
The influence of adsorption of native and modified antibodies on their activity. J Immunol Methods (1989) 0.93
Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model. Biochem Pharmacol (1989) 0.93
Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates. J Control Release (2001) 0.93
Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. J Control Release (2001) 0.93
HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro. Int J Cancer (1998) 0.92
Photodynamic crosslinking of proteins. II. Photocrosslinking of a model protein-ribonuclease A. J Photochem Photobiol B (1996) 0.92
High-molecular weight HPMA copolymer-adriamycin conjugates. J Control Release (1999) 0.91
Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts. J Control Release (1999) 0.91
Polymers containing enzymatically degradable bonds V. Hydrophilic polymers degradable by papain. Biomaterials (1980) 0.91
Polymers containing enzymatically degradable bonds. VI. Hydrophilic gels cleavable by chymotrypsin. Biomaterials (1982) 0.91
Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl)methacrylamide copolymers. A potential drug delivery system. Biochim Biophys Acta (1981) 0.91
A polymeric drug delivery system for the simultaneous delivery of drugs activatable by enzymes and/or light. J Biomater Sci Polym Ed (1994) 0.91
Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide copolymers. Biomaterials (1985) 0.90
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. Br J Cancer (1987) 0.90
Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice. Cancer Res (1996) 0.90
Photodynamic crosslinking of proteins. III. Kinetics of the FMN- and rose bengal-sensitized photooxidation and intermolecular crosslinking of model tyrosine-containing N-(2-hydroxypropyl)methacrylamide copolymers. Photochem Photobiol (1999) 0.90
Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation. Pharm Res (1992) 0.89
Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues. Biochim Biophys Acta (1983) 0.89
Prolonged blood circulation in rats of nanospheres surface-modified with semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]. Pharm Res (1995) 0.88
The influence of cytotoxicity of macromolecules and of VEGF gene modulated vascular permeability on the enhanced permeability and retention effect in resistant solid tumors. Pharm Res (2000) 0.88
Enantioselective release of 5-fluorouracil from N-(2-hydroxypropyl)methacrylamide-based copolymers via lysosomal enzymes. Bioconjug Chem (1995) 0.87
Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells. J Control Release (2007) 0.87
Biorecognizable HPMA copolymer-drug conjugates for colon-specific delivery of 9-aminocamptothecin. J Control Release (2001) 0.86
Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. J Control Release (2000) 0.86
Platelet adhesion to polymer surfaces. Trans Am Soc Artif Intern Organs (1974) 0.85
Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance. Biomaterials (2000) 0.85
Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody. Clin Immunol Immunopathol (1988) 0.85
Phagocytosis of human blood leukocytes: a simple micromethod. Immunol Lett (1982) 0.85
Water and hydrogels. J Biomed Mater Res (1973) 0.85
Photodynamic crosslinking of proteins. I. Model studies using histidine- and lysine-containing N-(2-hydroxypropyl)methacrylamide copolymers. J Photochem Photobiol B (1996) 0.85
Immunochemical detection by specific antibody to thrombin of prothrombin conformational changes upon adsorption to artificial surfaces. J Biomed Mater Res (1985) 0.85
Controlled release of drug model from N-(2-hydroxypropyl)-methacrylamide copolymers. Ann N Y Acad Sci (1985) 0.84
Protein adsorption on low-temperature isotropic carbon: I. Protein conformational change probed by differential scanning calorimetry. J Biomed Mater Res (1994) 0.84
Transarterial closed chest left ventricular bypass for desperate heart failure. J Assoc Adv Med Instrum (1973) 0.84
Calcification of nontextured implantable blood pumps. Trans Am Soc Artif Intern Organs (1981) 0.84
Immunogenicity of N-(2-hydroxypropyl)-methacrylamide copolymers--potential hapten or drug carriers. Folia Microbiol (Praha) (1983) 0.83
Responsive hybrid hydrogels with volume transitions modulated by a titin immunoglobulin module. Bioconjug Chem (2000) 0.83
Interaction of plasma proteins with heparinized gel particles studied by high-resolution two-dimensional gel electrophoresis. J Biomed Mater Res (1991) 0.83
Effect of the chemical structure of N-(2-hydroxypropyl)methacrylamide copolymers on their ability to induce antibody formation in inbred strains of mice. Biomaterials (1984) 0.83
The influence of a colonic microbiota on HPMA copolymer lectin conjugates binding in rodent intestine. J Drug Target (2001) 0.83
Coated adsorbents for direct blood perfusion II. Trans Am Soc Artif Intern Organs (1972) 0.83
Self-assembled peptides exposing epitopes recognizable by human lymphoma cells. Bioconjug Chem (2000) 0.83
New types of synthetic infusion solutions. III. Elimination and retention of poly-[N-(2-hydroxypropyl)methacrylamide] in a test organism. J Biomed Mater Res (1976) 0.83
Lysosomal degradability of poly(alpha-amino acids). J Biomed Mater Res (1997) 0.83
Biorecognition of HPMA copolymer-lectin conjugates as an indicator of differentiation of cell-surface glycoproteins in development, maturation, and diseases of human and rodent gastrointestinal tissues. J Biomed Mater Res (2000) 0.83
Synthesis of bioadhesive lectin-HPMA copolymer-cyclosporin conjugates. Bioconjug Chem (2000) 0.83
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia. Br J Cancer (1988) 0.83
The coiled coils in the design of protein-based constructs: hybrid hydrogels and epitope displays. J Control Release (2001) 0.83
Coated adsorbents for direct blood perfusion: HEMA-activated carbon. Trans Am Soc Artif Intern Organs (1971) 0.83
Surface modification and characterization of some commonly used catheter materials. II. Friction characterization. J Biomed Mater Res (1983) 0.83
Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers. Biomacromolecules (2000) 0.83
Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates. J Control Release (2001) 0.82
Specific immobilization of firefly luciferase through a biotin carboxyl carrier protein domain. Anal Biochem (1997) 0.82
Degradation of side-chains of N-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinases. Biosci Rep (1982) 0.82
Effect of galactose on interaction of N-(2-hydroxypropyl)methacrylamide copolymers with hepatoma cells in culture: preliminary application to an anticancer agent, daunomycin. Hepatology (1989) 0.82
Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro. Int J Oncol (1999) 0.82
The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in Hep G2 cells. AAPS PharmSci (2001) 0.82
Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugs. Int J Pharm (2007) 0.81
Modification of cyclosporin A and conjugation of its derivative to HPMA copolymers. Bioconjug Chem (2001) 0.81
Macrophages of athymic nude mice: Fc receptors, C receptors, phagocytic and pinocytic activities. Eur J Cell Biol (1984) 0.81
Adsorption of low density lipoproteins onto selected biomedical polymers. J Biomed Mater Res (1987) 0.81
Biological tolerance of poly(N-substituted acrylamides). J Biomed Mater Res (1973) 0.81
Effect of porosity of heterogeneous poly(glycol monomethacrylate) gels on the healing-in of test implants. J Biomed Mater Res (1971) 0.81
Enzyme electrodes. Science (1973) 0.81
Functionalized semitelechelic poly[N-(2-hydroxypropyl)methacrylamide] for protein modification. Bioconjug Chem (1999) 0.81
Release of macromolecules and daunomycin from hydrophilic gels containing enzymatically degradable bonds. J Biomater Sci Polym Ed (1990) 0.81
Potential of lectin-N-(2-hydroxypropyl)methacrylamide copolymer-drug conjugates for the treatment of pre-cancerous conditions. J Control Release (2001) 0.81
Blood-materials interactions: the minimum interfacial free energy and the optimum polar/apolar ratio hypotheses. J Biomed Mater Res (1982) 0.80
The foreign body reaction--an experimental protocol. J Biomed Mater Res (1974) 0.80
Biological tolerance of ionogenic hydrophilic gels. J Biomed Mater Res (1973) 0.80